307 related articles for article (PubMed ID: 30579607)
1. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells.
Cho MJ; Kim MJ; Kim K; Choi YW; Lee SJ; Whang YM; Chang IH
Biochem Biophys Res Commun; 2019 Jan; 509(1):167-174. PubMed ID: 30579607
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic effects of recombinant Bacillus Calmette-Guérin containing
Kim JH; Choi J; Kim M; Kang SJ; Choi YW; Choi SY; Kim SH; Chang IH
Investig Clin Urol; 2022 Mar; 63(2):228-237. PubMed ID: 35244998
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells.
Ding GQ; Yu YL; Shen ZJ; Zhou XL; Chen SW; Liao GD; Zhang Y
J Zhejiang Univ Sci B; 2012 May; 13(5):335-41. PubMed ID: 22556170
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model.
Chade DC; Borra RC; Nascimento IP; Villanova FE; Leite LC; Andrade E; Srougi M; Ramos KL; Andrade PM
J Exp Clin Cancer Res; 2008 Nov; 27(1):78. PubMed ID: 19040745
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
6. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in
Choi J; Jung TY; Kim JH; Maeng S; Kang SJ; Kim M; Choi YW; Choi SY; Kim SH; Chang IH
Investig Clin Urol; 2023 May; 64(3):296-305. PubMed ID: 37341010
[TBL] [Abstract][Full Text] [Related]
8. Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.
Luo Y; Henning J; O'Donnell MA
Clin Dev Immunol; 2011; 2011():728930. PubMed ID: 21941579
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
Dai FY; Wang JF; Gong XL; Bao L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy.
Lee CF; Chang SY; Hsieh DS; Yu DS
Cancer Gene Ther; 2004 Mar; 11(3):194-207. PubMed ID: 14973549
[TBL] [Abstract][Full Text] [Related]
11. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.
Zheng YQ; Naguib YW; Dong Y; Shi YC; Bou S; Cui Z
Expert Rev Vaccines; 2015; 14(9):1255-75. PubMed ID: 26268434
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
Liu W; O'Donnell MA; Chen X; Han R; Luo Y
Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
Yu DS; Lee CF; Hsieh DS; Chang SY
Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine.
Lee CF; Chang SY; Hsieh DS; Yu DS
J Urol; 2004 Mar; 171(3):1343-7. PubMed ID: 14767345
[TBL] [Abstract][Full Text] [Related]
15.
Rodriguez D; Goulart C; Pagliarone AC; Silva EP; Cunegundes PS; Nascimento IP; Borra RC; Dias WO; Tagliabue A; Boraschi D; Leite LCC
Front Immunol; 2019; 10():1460. PubMed ID: 31297119
[TBL] [Abstract][Full Text] [Related]
16. Recombinant hIFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer.
Sun E; Fan X; Wang L; Lei M; Zhou X; Liu C; Lu B; Nian X; Sun Y; Han R
Oncol Rep; 2015 Jul; 34(1):183-94. PubMed ID: 25998552
[TBL] [Abstract][Full Text] [Related]
17. Construction of recombinant human IFNα-2b BCG and its antitumor effects on bladder cancer cells in vitro.
Sun E; Nian X; Liu C; Fan X; Han R
Genet Mol Res; 2015 Apr; 14(2):3436-49. PubMed ID: 25966110
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma.
Arnold J; de Boer EC; O'Donnell MA; Böhle A; Brandau S
J Immunother; 2004; 27(2):116-23. PubMed ID: 14770083
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.
Takeuchi A; Eto M; Tatsugami K; Shiota M; Yamada H; Kamiryo Y; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Takahashi R; Yokomizo A; Ohara N; Yoshikai Y
Int Immunopharmacol; 2016 Jun; 35():327-331. PubMed ID: 27093372
[TBL] [Abstract][Full Text] [Related]
20. Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette-Guérin over-producing three putative protective antigen candidates.
Ohara N; Matsuoka M; Nomaguchi H; Naito M; Yamada T
Vaccine; 2001 Feb; 19(15-16):1906-10. PubMed ID: 11228360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]